FEATURED EVENTS

— Info Session Webinar —

Neurocovid: A Call to Action for Neuropsychologists

COVID-19 may lead to multiple neurological and neuropsychological complications: stroke (both ischemic and hemorrhagic), hypoxia, seizures, white matter damage, and various other forms of encephalopathy. Longitudinal studies of patients recovering from COVID-19 reveal generalized brain atrophy and inflammation, as well as focal lesions. There is also growing concern that COVID-19 infection may increase the risk of developing neurodegenerative disorders later in life. Lasting impairment of executive functions, memory, and other cognitive functions, as well as of smell and taste, have been demonstrated in recovered patients, whereas acute illness may be associated with delirium and psychosis. Even after the end of the pandemic, hundreds of thousands of individuals in the USA alone, and millions worldwide, will be afflicted with such lasting neuropsychological and neuropsychiatric sequelae of COVID-19. Neuropsychologists are uniquely qualified to play a central role in the diagnosis, counseling, and treatment of both acute and chronic neuro-COVID.

Elkhonon Goldberg, PhD

Elkhonon Goldberg, Ph.D., is an author, scientist, educator, and clinician, internationally renowned for his clinical work, research, writings, and teaching in neuropsychology and cognitive neuroscience. He is a Diplomate of The American Board of Professional Psychology in Clinical Neuropsychology and Director of Luria Neuroscience Institute. A student and close associate of the great neuropsychologist Alexander Luria, Elkhonon Goldberg has continued and advanced his scientific and clinical tradition.